Skip to content

Effect of salt reduction instruction on salt sensitivity

Effect of salt reduction instruction on salt sensitivity of patients with chronic kidney disease at community pharmacy - My-BP study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1042240064
Enrollment
18
Registered
2024-07-30
Start date
2024-07-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease chronic kidney disease

Interventions

The starting date of salt reduction instruction at the insurance pharmacy shall be Day 1 and shall continue until Day 84. The salt reduction instruction is given at each visit to the insurance pharmac
D018529
salt resriction

Sponsors

Murata Tomohiro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ) Disease name and diagnosis: Patients with eGFR less than 60 mL/min/1.73 m2. 2) Stage and type of disease: CKD severity classification G3a or higher 3) Age: 18 years and older 4) Indicators of systemic status: any 5) Relevant major organ function: kidney 6) Documented patient consent: required

Exclusion criteria

Exclusion criteria: 1) Inability to continuously record blood pressure at home upon waking (or in the morning) 2) Unable to visit the insurance pharmacy of the collaborating institution for 3 months 3) Difficulty in communication 4) Patient is on maintenance dialysis 5) Receives medication on a refill prescription 6) Waking (or morning) blood pressure below 90/60 mmHg or dizziness due to low blood pressure 7) Taking salt as a prescription medication 8) Persons who are considered by the principal investigator or research associate to be inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
Salt sensitivity with Solseve before and after intervention: mean of 6 levels of Solseve taste index 0.6%, 0.8%, 1.0%, 1.2%, 1.4%, and 1.6%.

Secondary

MeasureTime frame
1. salt sensitivity by SolSave : percentage of improvement of 0.2% or more of 6 levels of SolSave taste index 0.6%, 0.8%, 1.0%, 1.2%, 1.4%, and 1.6%. 2. estimated salt intake calculated from urine at any time 3. average blood pressure upon waking (or in the morning) during the week 4. survey of patients' attitudes toward salt reduction 5. eGFR 6. urinary protein 7. variation in serum Na concentration 8. variation of serum K concentration 9. variation of hemoglobin level

Countries

Japan, non

Contacts

Public ContactYuki Asai

Mie University hospital

yuki-asai@med.mie-u.ac.jp+81-7022470221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026